Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tango Therapeutics
Biotech
Metsera sale architect swings to Structure—Chutes & Ladders
Metsera acquisition architect swings to Structure. Vir CMO exits after less than 2 years. Leal reels in Big Pharma vets to exec team.
Darren Incorvaia
,
Zoey Becker
,
Will Maddox
Apr 17, 2026 10:10am
Bavarian Nordic CEO exits after failed takeover—Chutes & Ladders
Mar 6, 2026 8:30am
Former Roche oncology head turns to Tubulis—Chutes & Ladders
Jan 9, 2026 8:30am
Sanofi snags CMO from BioMarin—Chutes & Ladders
Aug 29, 2025 8:30am
Tango dances away from preclinical work to extend cash runway
May 12, 2025 8:37am
Tango axes PRMT5 inhibitor, shifts focus to 2 sibling molecules
Nov 6, 2024 8:28am